Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid

Gastroenterology

Volumn 136, Issue 4, 2009, Pages 1281-1287

  Kuiper, Edith M M ^a   Hansen, Bettina E ^a   de Vries, Richard A ^b   den Ouden Muller, Jannie W ^c   van Ditzhuijsen, Theo J M ^d   Haagsma, Els B ^b   Houben, Martin H M G ^e   Witteman, Ben J M ^f   van Erpecum, Karel J ^g   van Buuren, Henk R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c SINT FRANCISCUS GASTHUIS   (Netherlands)

^d JEROEN BOSCH HOSPITAL   (Netherlands)

^e HAGA HOSPITAL   (Netherlands)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 62949221007     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.01.003     Document Type: Article

References (19)

1. Heathcote E.J. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 31 (2000) 1005-1013
2. Gong Y., Huang Z., Christensen E., et al. Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. Am J Gastroenterol 102 (2007) 1799-1807
3. Jorgensen R.A., Dickson E.R., Hofmann A.F., et al. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut 36 (1995) 935-938
4. Poupon R.E. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past-issues for the future. J Hepatol 32 (2000) 685-688
5. van Hoogstraten H.J., Hansen B.E., van Buuren H.R., et al. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group. J Hepatol 31 (1999) 256-262
6. Corpechot C., Carrat F., Bahr A., et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128 (2005) 297-303
7. Paumgartner G. Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. J Hepatol 39 (2003) 112-114
8. Angulo P., Lindor K.D., Therneau T.M., et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 19 (1999) 115-121
9. Pares A., Caballeria L., and Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 130 (2006) 715-720
10. Corpechot C., Abenavoli L., Rabahi N., et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology 48 (2008) 871-877
11. ter Borg P.C., Schalm S.W., Hansen B.E., et al. Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 101 (2006) 2044-2050
12. Taal B.G., Schalm S.W., Ten Kate F.W., et al. Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepatogastroenterology 30 (1983) 178-182
13. Ludwig J., Dickson E.R., and McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379 (1978) 103-112
14. Angulo P., Jorgensen R.A., and Lindor K.D. Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?. Am J Gastroenterol 96 (2001) 3152-3157
15. Dickson E.R., Grambsch P.M., Fleming T.R., et al. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10 (1989) 1-7
16. Silveira M.G., and Lindor K.D. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clin Liver Dis 12 (2008) 425-443
17. Poupon R.E., Bonnand A.M., Chretien Y., et al. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology 29 (1999) 1668-1671
18. Koulentaki M., Moscandrea J., Dimoulios P., et al. Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Dig Dis Sci 49 (2004) 1190-1195
19. Corpechot C., Carrat F., Bonnand A.M., et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology 32 (2000) 1196-1199